Immunotherapy of Cancer (Record no. 247343)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04571nam a22004695i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-59745-011-9 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20160614135352.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 100301s2006 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781597450119 |
| -- | 978-1-59745-011-9 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1385/1597450111 |
| Source of number or code | doi |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | Alfaisal Main Library |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC261-271 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJCL |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED062000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 614.5999 |
| Edition number | 23 |
| 245 10 - TITLE STATEMENT | |
| Title | Immunotherapy of Cancer |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Mary L. Disis. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS | |
| Place of production, publication, distribution, manufacture | Totowa, NJ : |
| Name of producer, publisher, distributor, manufacturer | Humana Press, |
| Date of production, publication, distribution, manufacture | 2006. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XII, 516 p. 52 illus. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Cancer Drug Discovery and Development |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches -- Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens -- Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy -- The Role of Immune Monitoring in Evaluating Cancer Immunotherapy -- Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials -- DNA Vaccines for Cancer Immunotherapy -- Dendritic Cells -- Different Approaches to Dendritic Cell-Based Cancer Immunotherapy -- Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer -- Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics -- Tumor-Reactive T-Cells for Adoptive Immunotherapy -- T-Cell Adoptive Immunotherapy of Cancer -- Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells -- Harnessing the Potential of Graft-vs-Tumor -- Tumor-Induced Immune Suppression and Immune Escape -- The Tumor Microenvironment -- Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity -- Fast-Lane Evolution in the Tumor Microenvironment -- Manipulating Immunological Checkpoints to Maximize Antitumor Immunity -- Interleukin-2 as Cancer Therapy -- Biological and Clinical Properties of the Type 1 Interferons -- Promising ?-Chain Cytokines for Cancer Immunotherapy -- The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies -- Antibody Therapy for Solid Tumors -- Antibody Therapy for Non-Hodgkin’s Lymphoma -- Approaches to In Vivo Imaging of Cancer Immunotherapy -- Design Issues for Early-Stage Clinical Trials for Cancer Vaccines -- Monoclonal Antibody Therapy of Cancer. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Major scientific advances in molecular and clinical immunology have produced tremendous growth in our understanding of how cancer is recognized by the immune system, as well as in our ability to control and modulate that recognition. In Immunotherapy of Cancer, expert bench and clinical scientists join forces to concurrently review both the state of the art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T-cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunological monitoring-and the new advances and directions in cancer immunotherapy are also fully examined. Comprehensive and cutting-edge, Immunotherapy of Cancer offers immunologists an exhaustive and authoritative survey of cancer immunotherapy, as well as providing a springboard for applying the most important findings in tumor immunology to any basic laboratory program or clinical oncology practice. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer research. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedicine. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | local |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Disis, Mary L. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781588295644 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Cancer Drug Discovery and Development |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1385/1597450111">http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1385/1597450111</a> |
| 912 ## - | |
| -- | ZDB-2-SBL |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | eBooks |
No items available.